Robert A. Drugge, a director of Timberland Bancorp Inc, has reported a transaction involving the acquisition of 195 shares of the company’s common stock. This transaction, which occurred on September 28, 2026, is significant as it highlights ongoing financial activities at the company and may impact shareholder perceptions.
Timberland Bancorp Inc, identified under the Central Index Key (CIK) 0001046050, operates within the savings institutions sector, specifically classified as savings institutions, not federally chartered. The company is based in Hoquiam, Washington, and its fiscal year ends on September 30. The recent filing indicates that Drugge currently owns a total of 38,050 shares following this transaction.
According to the filing, Drugge’s transaction was executed at a price of $45.41 per share. The filing states, "As previously reported 200 shares of restricted stock vested on September 26, 2026, of which 195 shares were withheld at the election of the Reporting Person for Issuer to pay the value of the vested shares to state and federal tax authorities for the Reporting Person's account." This indicates that the transaction was primarily for tax purposes related to the vesting of restricted stock.
The implications of this transaction may extend to shareholders and potential investors, as it reflects the financial activities of a key director at Timberland Bancorp. Such disclosures can influence market perceptions and regulatory scrutiny, particularly in the savings institution sector where transparency is crucial.
Details were not available in the SEC filing regarding any future actions or upcoming votes related to this transaction. However, the ongoing reporting of stock transactions by company insiders like Drugge is a standard practice aimed at maintaining transparency in the financial markets.